Overview - As demand for GLP-1 drugs continues to skyrocket, federal and state agencies are turning their attention to the GLP-1 ...

Aardvark Therapeutics (AARD) announced new positive preclinical data demonstrating the potential of ARD-201 for the treatment of metabolic obesity ...

The obesity market still only has two clear leaders with approved GLP-1 medications, and frontrunners Eli Lilly and Novo ...

The Government has announced a pilot to test new ways to support patients living with obesity, in a bid to ease pressures on ...

New studies indicate that weight-loss drugs may lead to serious eye diseases and vision loss in some individuals, prompting ...

The partnership means that Apple's fitness and wellness service will be made available to all members who enrol onto ...

New studies confirm a small increased risk of serious eye conditions and vision loss in people taking weight-loss drugs like Ozempic, Wegovy, and Mounjaro.

Two studies were conducted to verify concerns about diabetic retinopathy that were raised during initial trials of ...

"Tirzepatide and other drugs like it, such as semaglutide, will help people living with obesity to lose weight, and as a ...

A significant issue is under enrollment of women in randomized trials, meaning the percentage of women enrolled isn’t in line ...

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Fat jabs could soon be available over the counter at pharmacies without the need for a GP, according to rppeorts. Fat jabs ...